China Grand Automotive Services Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Grand Automotive Services Co Ltd with three other
pharmaceutical manufacturers in Asia:
Kangmei Pharmaceutical Co Ltd
sales of 21.61 billion Chinese Renmimbi [US$3.20 billion]
of which 87%
Sun Pharmaceuticals Industries Ltd
(282.70 billion Indian Rupees [US$4.40 billion]
of which 100%
was Pharmaceuticals), and
Sumitomo Dainippon Pharma Co Ltd
based in Japan
(403.21 billion Japanese Yen [US$3.60 billion]
During the year ended December of 2016, sales at
China Grand Automotive Services Co Ltd were 135.39 billion Chinese Renmimbi (US$20.07 billion).
increase of 44.7%
versus 2015, when the company's sales were 93.58 billion Chinese Renmimbi.
Sales of Automobile Sales saw an increase
45.5% in 2016, from
91.85 billion Chinese Renmimbi to 133.68 billion Chinese Renmimbi.
Not all segments of China Grand Automotive Services Co Ltd experienced an increase in sales in 2016:
sales of Automobile Leasing fell 4.2% to 1.89 billion Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).